Fig. 2From: UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinomaAnalysis of metabolic profiling between cancers and controls. (a) Metabolic score plot of OPLS-DA.(b) Relative intensity between the cancers and controls. (c) ROC curve with 10-fold cross validation based on the biomarker panel. (d) ROC curve of external validation based on the biomarker panelBack to article page